BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Head and neck cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. STAT6
    [Clinical Outcome] [Diagnosis] [